Pre-market hot trades in US stocks: Wolfspeed up 7.14% in pre-market

Popular Pre-Market Trades in US Stocks

Wolfspeed is up 7.14% in pre-market trading. Based on recent important news:

1. On January 20, Wolfspeed's stock price fell 57% last year, the CEO suddenly resigned, and ratings were downgraded multiple times, as the company is undergoing a significant business transformation aimed at becoming a leading chip design and manufacturing enterprise, leading to stock price volatility.

2. On January 19, news that Anhui will lead the national biopharmaceutical alliance's centralized procurement caused stock prices of several innovative drug companies to drop, with Innovent Biologics experiencing the largest decline of over 10%.

3. On January 17, data from the U.S. Treasury Department showed that in November 2024, Japan, the top three overseas holders of U.S. debt, reduced its holdings, while China and the UK increased theirs.

Top Gainers in Pre-Market US Stocks

Scage Future is up 97.14% in pre-market trading. Based on recent important news:

1. On June 24, the Middle East announced a ceasefire, leading to a surge in the stock markets of Japan and South Korea, and the A-shares continued to rebound after opening, releasing a huge volume, boosting market sentiment, and significantly increasing Scage Future's stock price.

2. On June 10, Rongda Technology opened 66% higher in the dark market, and the optimistic sentiment towards tech stocks spread, driving related sectors up.

3. On June 8, the market was poised for an upward attack, with significant sector rotation, as investors expected the market to continue rising, pushing Scage Future's stock price up.

Sobr Safe is up 62.61% in pre-market trading. Based on recent important news:

1. On June 23, Yaojie Ankang-B was listed on its first day, with the opening price rising 64.6% compared to the listing price, driving enthusiasm for new stocks and boosting related sectors.

2. On June 25, Safe Warehouse released its annual performance, with a net loss expanding by 116.5% year-on-year, but the stock price remained flat, indicating the market's digestion of its performance.

3. On June 26, Yaojie Ankang-B surged nearly 5% in the closing session, as the market held an optimistic view of its future performance, driving the stock price up.

Calidi Biotherapeutics is up 54.09% in pre-market trading. Based on recent key news:

1. On July 8, Calidi Biotherapeutics announced that it was mentioned in an editorial published by NetworkNewsWire, increasing market attention towards it, leading to a 54.09% pre-market stock price increase